This section covers the managerial aspects in the Pharma industry.
DARMSTADT Germany and NEW YORK October 31 2016 PRNewswire If approved avelumab an investigational antiPDL1 IgG1 could be the first treatment indicated for patients with metastatic Merkel cell carcinoma TheMarketing Authorization Applicationis based on Phase II datafrom the JAVELIN Merkel 200 s..
LONDON October 31 2016 PRNewswire Arix Bioscience plc Arix Bioscience a global healthcare and life science company supporting medical innovation announced today that it had appointed Dr Franz B Humer as its Senior Independent Director Dr Humer is one of the pharmaceutical industrys most respect..
ANN ARBOR Mich Oct 31 2016 GLOBE NEWSWIRE Kraig Biocraft Laboratories Inc OTCQBKBLB Company the leading developer of spider silk based fibers today announced it has created a new line of genetically engineered silkworms that rival the Companys Dragon Silkfor the title as worlds strongest and m..
NEWTON Mass Oct 31 2016 GLOBE NEWSWIRE Karyopharm Therapeutics Inc NasdaqKPTI a clinicalstage pharmaceutical company announced today that it will report third quarter 2016 financial results and provide a company update on Monday November 7 2016 Karyopharms management team will host a conferenc..
CSE IN OTCQB IMLFF VANCOUVER Oct 31 2016 PRNewswire InMed Pharmaceuticals Inc InMed CSE IN OTCQB IMLFF today announced the appointment of Alexandra DJ Mancini MSc as Senior Vice President Clinical and Regulatory Affairs Ms Mancini has over 30 years global biopharmaceutical RD experience with ..
PARIS Oct 31 2016 PRNewswire The 2016 World Cancer Congress WCC in Paris a global gathering of more than 3500 cancer experts will be the setting for the introduction of a new enhanced version of the PACE Continuous Innovation Indicators CII by PACE Patient Access to Cancer care Excellence a Lil..
SHELTON Conn Oct 31 2016 PRNewswire NanoViricides Inc NYSE MKT NNVC the Company announced today that it has entered into an agreement with SUNY Upstate Medical University for the testing of its nanoviricides drug candidates against varicella zoster virus ie the shingles virus The research will ..
HACKENSACK NJand PETACH TIKVAHIsrael Oct31 2016 PRNewswire BrainStorm Cell Therapeutics IncNASDAQ BCLI a leading developer of adult stem cell therapeutics for neurodegenerative diseases announced that it has been granted United States Patent No 9474787titled Mesenchymal Stem Cells for the Treatme..
REDWOOD CITY Calif Oct 31 2016 PRNewswire AcelRx Pharmaceuticals Inc NASDAQ ACRX a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderatetosevere acute pain announced an upcoming poster presentation at The Obesity So..
WARSAW Ind Oct 31 2016 PRNewswire Zimmer Biomet Holdings Inc NYSE and SIXZBH today reported financial results for the quarter ended September 30 2016 The Company reported third quarter net sales of 183 billion an increase of 40 compared to the third quarter of 2015 On an adjusted constant currency..
CAMBRIDGE Mass Oct 31 2016 PRNewswire Merrimack Pharmaceuticals IncNASDAQ MACK today announced that the US Food and Drug Administration FDA has accepted for review the Abbreviated New Drug Application ANDA for generic doxorubicin hydrochloride HCI liposome injection submitted by its partner Actavi..
NEW YORK and OSAKA Japan Oct 31 2016 PRNewswire Memorial Sloan Kettering Cancer Center The Rockefeller University and Weill Cornell Medicine announced today that they have established a new drug discovery company called Bridge Medicines Launched in partnership with Takeda Pharmaceutical Company Lt..
AHMEDABAD India October 31 2016 PRNewswire Zydus Cadila today announced that new data of Saroglitazar will be presented at The Liver Meeting being held at the John B Hynes Veterans Memorial Convention Center Boston from 11th to 15th of November 2016 Scientific abstract describing the attenuatin..
NORTH CHICAGO Ill Oct 31 2016 PRNewswire AbbVie NYSE ABBV will participate in the 25th Annual Credit Suisse Healthcare Conference on Tuesday November 8 2016 Richard Gonzalez chairman of the board and chief executive officer will participate in a question and answer session at 1200 pm Central time..
MINNEAPOLIS Oct 31 2016 PRNewswire BioTechne Corporation NASDAQTECH announced that its Board of Directors has decided to pay a dividend of 032 per share for the quarter ended September 30 2016 The quarterly dividend will be payable November 28 2016 to all common shareholders of record on November ..
CAMBRIDGE Mass Oct 31 2016 PRNewswire Infinity Pharmaceuticals Inc NASDAQ INFI will host a conference call on Monday November 7 2016 at 430 pm ET During the call management will review the companys third quarter 2016 financial results and provide an update on Infinitys business A live webcast of..
WOODCLIFF LAKE NJ Oct 31 2016 PRNewswire Eisai Inc announced today that enrollment has begun in the USfor MISSIONAD a Phase 3 clinical program for E2609 a Betasecretase Cleaving Enzyme BACE inhibitor for patients with early Alzheimers disease E2609 was discovered by Eisai and is being jointly deve..
WOODCLIFF LAKE NJ and STAMFORD Conn Oct31 2016 PRNewswire Eisai Inc and Purdue Pharma LP announced today the initiation of a multicenter randomized Phase 2 clinical study Study 202 to evaluate Eisais internallydiscovered oral dual orexin receptor antagonist lemborexant E2006 in patients with mild ..
SAN DIEGO October 31 2016 PRNewswire Regen BioPharma Inc OTCQB RGBP OTCQB RGBPP today announced its strategy for developing its novel NR2F6 small molecule modulators Regen has recently filed a composition of matter patent application covering these novel NR2F6 small molecule modulators Having r..
TEL AVIV Israel Oct 31 2016 PRNewswire Galmed Pharmaceuticals Ltd Nasdaq GLMD Galmed or the Company a clinicalstage biopharmaceutical company focused on the development of a oncedaily oral therapy for the treatment of liver diseases announced today that it will host a conference call and webcast ..